Published in Epidemiology on July 01, 2013
Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study. J Bone Miner Res (2015) 0.82
Acid-suppressive medications and risk of fracture: an updated meta-analysis. Int J Clin Exp Med (2015) 0.76
Risk of falls associated with antiepileptic drug use in ambulatory elderly populations: A systematic review. Can Pharm J (Ott) (2017) 0.75
Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57
Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ (2011) 2.01
Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer (2003) 1.98
Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study. Neurology (2011) 1.97
Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med (2007) 1.95
Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol (2004) 1.95
Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol (2002) 1.92
Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol (2006) 1.90
Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. Pharmacoepidemiol Drug Saf (2011) 1.85
Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J (2011) 1.82
A population-based study showing an association between gastroesophageal reflux disease and sleep problems. Clin Gastroenterol Hepatol (2009) 1.71
Chest pain in general practice: incidence, comorbidity and mortality. Fam Pract (2006) 1.62
Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med (2006) 1.62
Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis Rheum (2010) 1.61
The prognosis for individuals on disability retirement. An 18-year mortality follow-up study of 6887 men and women sampled from the general population. BMC Public Health (2006) 1.54
Self-reported use of pharmaceuticals among patients with irritable bowel syndrome in primary care. J Manag Care Pharm (2008) 1.45
Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause (2006) 1.43
Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation. Thromb Haemost (2013) 1.43
Risk of cerebrovascular accident after a first diagnosis of atrial fibrillation. Clin Cardiol (2007) 1.39
Incidence and risk factors for atrial fibrillation in patients with newly diagnosed heart failure. J Cardiovasc Med (Hagerstown) (2016) 1.38
Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovasc Disord (2005) 1.34
Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications. Circulation (2011) 1.33
Positive predictive value of computerized medical records for uncomplicated and complicated upper gastrointestinal ulcer. Pharmacoepidemiol Drug Saf (2009) 1.30
Contemporary epidemiology of gout in the UK general population. Arthritis Res Ther (2011) 1.26
Sick-leave track record and other potential predictors of a disability pension. A population based study of 8,218 men and women followed for 16 years. BMC Public Health (2009) 1.23
Morbidity associated with sleep disorders in primary care: a longitudinal cohort study. Prim Care Companion J Clin Psychiatry (2007) 1.23
Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology (2006) 1.21
A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China. BMC Gastroenterol (2010) 1.16
Geriatric drug therapy and healthcare utilization in the United kingdom. Ann Pharmacother (2002) 1.15
Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival. Diabetes Care (2012) 1.12
Nonsteroidal anti-inflammatory drugs and risk of lung cancer. Int J Cancer (2007) 1.12
Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.11
Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study. Respir Med (2010) 1.11
Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Fam Pract (2009) 1.10
Association between captopril, other antihypertensive drugs and risk of prostate cancer. Prostate (2004) 1.08
The incidence of bleeding complications associated with warfarin treatment in general practice in the United Kingdom. Br J Gen Pract (2003) 1.08
Acid-suppressive drugs and community-acquired pneumonia. Epidemiology (2009) 1.06
Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity, and treatment patterns. Prim Care Companion J Clin Psychiatry (2010) 1.06
Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest (2008) 1.05
Respiratory medications and the risk of cardiac arrhythmias. Epidemiology (2005) 1.05
Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-inflammatory therapy. Gastroenterology (2011) 1.03
The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care. Pharmacoepidemiol Drug Saf (2008) 1.03
Systematic investigation of gastrointestinal diseases in China (SILC): validation of survey methodology. BMC Gastroenterol (2009) 1.03
Survival after stroke--the impact of CHADS2 score and atrial fibrillation. Int J Cardiol (2009) 1.01
Diabetes in patients with idiopathic Parkinson's disease. Diabetes Care (2008) 1.01
Effects of self-rated health on sick leave, disability pension, hospital admissions and mortality. A population-based longitudinal study of nearly 15,000 observations among Swedish women and men. BMC Public Health (2012) 1.01
The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: the Nord-Trøndelag health survey. Chest (2006) 1.00
Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome? Maturitas (2003) 1.00
Epidemiology of peptic ulcer disease: endoscopic results of the systematic investigation of gastrointestinal disease in China. Am J Gastroenterol (2010) 0.99
Breast cancer risk among users of antidepressant medications. Epidemiology (2005) 0.99
Migraine and the risk of stroke, TIA, or death in the UK (CME). Headache (2007) 0.99
Risk of irritable bowel syndrome among asthma patients. Pharmacoepidemiol Drug Saf (2002) 0.99
Gastroesophageal reflux disease in children and adolescents in primary care. Scand J Gastroenterol (2010) 0.96
Stressful psychosocial factors and symptoms of gastroesophageal reflux disease: a population-based study in Norway. Scand J Gastroenterol (2010) 0.96
Health-related quality of life of irritable bowel syndrome patients in different cultural settings. Health Qual Life Outcomes (2006) 0.95
Cancer risk in association with Parkinson disease: a population-based study. Parkinsonism Relat Disord (2009) 0.95
Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden. BMC Public Health (2008) 0.95
Psychosocial factors at work and in every day life are associated with irritable bowel syndrome. Eur J Epidemiol (2007) 0.94
Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care. Drug Saf (2011) 0.94
Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal diseases in China (SILC). Scand J Gastroenterol (2010) 0.94
Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract (2007) 0.92
Esophageal stricture: incidence, treatment patterns, and recurrence rate. Am J Gastroenterol (2006) 0.92
A population-based case-control study of work and psychosocial problems in patients with irritable bowel syndrome--women are more seriously affected than men. Am J Gastroenterol (2006) 0.92
Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol (2008) 0.92
Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation. BMC Cardiovasc Disord (2002) 0.91
Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism. Thromb J (2008) 0.91
Cancer incidence in a general population of asthma patients. Pharmacoepidemiol Drug Saf (2006) 0.90
Results from a rosuvastatin historical cohort study in more than 45,000 Dutch statin users, a PHARMO study. Pharmacoepidemiol Drug Saf (2006) 0.89
Relation between gastroesophageal reflux symptoms and socioeconomic factors: a population-based study (the HUNT Study). Clin Gastroenterol Hepatol (2007) 0.88
Gallbladder disease in the general population: association with cardiovascular morbidity and therapy. Pharmacoepidemiol Drug Saf (2007) 0.87
Controversies in COX-2 selective inhibition. J Rheumatol (2002) 0.86
Impact of gastroesophageal reflux disease on daily life: the Systematic Investigation of Gastrointestinal Diseases in China (SILC) epidemiological study. Health Qual Life Outcomes (2010) 0.86
Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates? Pharmacoepidemiol Drug Saf (2011) 0.85
Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics. Pharmacoepidemiol Drug Saf (2012) 0.85
Chest pain without established ischaemic heart disease in primary care patients: associated comorbidities and mortality. Br J Gen Pract (2009) 0.84
Helicobacter pylori infection and gastritis: the Systematic Investigation of gastrointestinaL diseases in China (SILC). J Gastroenterol Hepatol (2011) 0.84
Low-dose aspirin and upper gastrointestinal bleeding in primary versus secondary cardiovascular prevention: a population-based, nested case-control study. Circ Cardiovasc Qual Outcomes (2013) 0.84
Risk of complications after a peptic ulcer diagnosis: effectiveness of proton pump inhibitors. Dig Dis Sci (2013) 0.84
A population-based study of nearly 15 000 observations among Swedish women and men during 1973-2003. BMJ Open (2012) 0.83
The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases. Pharmacoepidemiol Drug Saf (2008) 0.83
Body mass index, coronary heart disease and stroke in Swedish women. A prospective 19-year follow-up in the BEDA study. Eur J Cardiovasc Prev Rehabil (2003) 0.83
Measuring the frequency of functional gastrointestinal disorders in rural Crete: a need for improving primary care physicians' diagnostic skills. Rural Remote Health (2005) 0.83
Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors. COPD (2009) 0.83
Prescription of antihypertensive medications during pregnancy in the UK. Pharmacoepidemiol Drug Saf (2014) 0.82
Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response. Scand J Gastroenterol (2012) 0.82
Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice. Chest (2005) 0.82
Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice. Eur J Heart Fail (2015) 0.81
Users of oral steroids are at a reduced risk of developing irritable bowel syndrome. Pharmacoepidemiol Drug Saf (2003) 0.81
Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link? Dig Dis Sci (2008) 0.81
Comparison of gastro-oesophageal reflux disease and heartburn diagnoses in UK primary care. Curr Med Res Opin (2006) 0.81
Use of angiotensin II receptor blockers and the risk of acute pancreatitis: a nested case-control study. Pancreatology (2010) 0.81
Sex differences in dietary coping with gastrointestinal symptoms. Eur J Gastroenterol Hepatol (2010) 0.81
Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins. Pharmacoepidemiol Drug Saf (2010) 0.81
Antibiotic use and the risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.80
Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study. Clin Gastroenterol Hepatol (2007) 0.80
Epidemiology of meningioma in the United Kingdom. Neuroepidemiology (2012) 0.80